Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD

View source ↗

Summary

A clinical trial updating Fontan outcomes in univentricular congenital heart disease, comparing oligemia versus plethora, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sisca Natalia Siagian | Conditions: Congenital Heart Disease (CHD), Univentricular Heart | Status: RECRUITING